As core skeletons of lamellarins: 5,6-Dihydropyrrolo[2,1-a]isoquinolines are one of the important alkaloids that exhibit significant biological activities, in this study, an efficient synthetic route was described for two novel compounds, 5,6-dihydropyrrolo[2,1-a]isoquinolines I and II. Compound I was synthesized from isovanillin with 28.3% overall yield by a six-step reaction while II from 2-(3, 4-dimethoxyphenyl) ethanamine was with 61.6% overall yield by a three-step reaction. And the structures of these two compounds were confirmed by means of IR spectrum, 1 H NMR, 13 C NMR, MS, HRMS, and melting point measurements.
Introduction
Lamellarins are a group of hexacyclic marine alkaloids that were initially isolated from a prosobranch mollusk by Faulkner and coworkers in 1985 [1] . Since then, over 70 compounds belonging to this group have been isolated and identified [2] .
Some of these lamellarins and related compounds exhibit interesting biological activities in multidrug resistance (MDR) and their corresponding parental cell lines [3] . As well known [4] , Lamellarin D (LMD) exhibits a significant cytotoxicity against a large panel of cancer cell lines and is a potential non-CPT (camptothecin) topoisomerase 1 poison [5, 6] . LMD affects cell cycle and acts on cancer cell mitochondria to induce apoptosia [7] .
Due to the fascinating novel structures and biological activities, more and more researchers have devoted into the synthetic studies of lamellarins [8] and related 3,4-diarylpyrrolo derivatives. As one of the important alkaloids, 5,6-Dihydropyrrolo[2,1-a]isoquinolines exhibits pronounced biological activities. The biological activity of 5,6-dihydropyrrolo[2,1-a]isoquinolines I and II was evaluated by their effects on the proliferation of MDA-MB-231 (breast cancer cell line) by MTT assay. Our results showed that compound I could significantly inhibit the proliferation of MDA-MB-231 at the concentration of 40 μg/mL, in contrast, compound II could enhance the proliferation of the MDA-MB-231 at the same concentration. In addition, they are also scaffolds for synthesis of lamellarin analogues [9] .
Increasingly elegant synthetic routes have been developed. An efficient synthetic route for two compounds, 8-benzyloxy-9-methoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydropyrrolo[2,1-a]isoquinoline (I) and 8,9-dimethoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydro[2,1-a]isoquinoline (II), is mainly introduced in this study. The synthetic procedure is very valuable because it employs 5,6-dihydropyrrolo[2, 1-a]isoquinolines as starting materials and represents an easy and direct approach to a wide variety of 3,4-dihydroisoquinolines. The synthetic strategy is outlined in Scheme 1.
Isovanillin was protected with benzyl chloride to get 3-benzyloxy-4-methoxy-benzaldehyde (1) with 84.4% yield [10] , which was condensed with nitromethane giving 2-benzyloxy-1-methoxy-4-(2-nitrovinyl)-benzene (2) with 80.5% yield [11] . Compound 2 was then reduced with LiAlH 4 to get 2-(3-benzyloxy-4-methoxyphenyl)-vinylamine (3) with 84.9% yield [12] . Treatment of 3a∼b with acetylchloride (n(3a∼b):n(CH 3 COCl):n(Et 3 N)=1:1.8: 4.0) afforded acetamide (4a∼b) with 81.9% and 90.7% yield, respectively, followed by cyclization with phosphorous oxychloride to get 3,4-dihydroisoquinoline (5a∼b) with 80.0% and 83.6% yield (n(4a) : n(POCl 3 ) = 1 : 8 
Material and Methods

Analysis Means of Compounds.
Melting points (uncorrected) were determined by a Gongyi X-4 apparatus. Infrared spectra(IR) were determined by Nicolet 550 spectrometer. NMR spectra were recorded by Bruker DRX500 or Bruker DRX400 spectrometer. All data were calibrated at δ 0.00 ppm for 1 H spectra and 13 C spectra from the original spectra (TMS). Low resolution mass spectra (LRMS) were recorded with an HP 6890/5973 GC-MS mass spectrometer. High resolution mass (HRMS) for unreported compounds were recorded with a Micromass GTC Gas Chromatography/TOF Mass spectrometer. All solvent were redistilled prior to use, unless otherwise stated, all other commercially available chemicals were used without further purification.
Chemical Synthesis
3-(benzyloxy)-4-methoxybenzaldehyde (1).
A mixture of isovanillin (10.0 g, 66 mmol), benzyl chloride (16 mL, 139 mmol), and anhydrous K 2 CO 3 (6.5 g, 47 mmol) in EtOH (150 mL) was refluxed for 5 h. After being stirred, the reaction mixture was concentrated to dry and redissolved in 70 mL CH 2 Cl 2 , and then 5% aqueous NaOH (3 × 100 mL) was added. The organic layer was washed with brine (2 × 50 mL) and H 2 O (2 × 50 mL), dried with anhydrous Na 2 SO 4 , and evaporated to dryness. Needles were obtained after crystallization from MeOH/CH 2 Cl 2 corresponding to 3-(benzyloxy)-4-methoxybenzaldehyde (15.0 g, 94%): m.p.
61∼62
• C (lit. 13 m.p. 
(E)-2-(benzyloxy)-1-methoxy-4-(2-nitrovinyl)benzene (2).
A solution of compound 1 (10.0 g, 41 mmol), nitromethane (7 mL, 129 mmol) and NH 4 OAc (8.0 g, 104 mmol) in AcOH (125 mL) was refluxed for 4 h. After cooling, the mixture was diluted with H 2 O (100 mL) and extracted with CH 2 Cl 2 (3 × 100 mL). The organic solution was washed with brine (2 × 100 mL) and H 2 O (2 × 100 mL), dried with anhydrous Na 2 SO 4 , and evaporated to dryness. Yellow needles were obtained from EtOH corresponding to (E)-2-(benzyloxy)-1-methoxy-4-(2-nitrovinyl)benzene (2) (9.6 g, 80.5%): m.p. 127∼128
• C (lit. 14 m.p. 
2-(3-(benzyloxy)-4-methoxyphenyl)ethanamine (3).
A solution of compound 2 (4.0 g, 14.0 mmol) in 14 mL of anhydrous THF was added dropwise to a well-stirred suspension of LiAlH 4 (2.0 g, 52.8 mmol) in 50 mL of anhydrous THF and was refluxed for 6 h. After the solution was cooled, the excess reagent was destroyed by dropwise addition of EtOAc and 15% aqueous NaOH. After partial evaporation of the filtered portion, the aqueous solution was extracted with CH 2 Cl 2 (3 × 30 mL), and the organic solution was washed with brine (2 × 20 mL) and H 2 O (2 × 20 mL), dried with anhydrous Na 2 SO 4 , and evaporated to dryness, and then 2-(3-(benzyloxy)-4-methoxyphenyl)ethanamine (3) (3.0 g, 84.9%) was obtained as an oil. 1 
N-(3-(benzyloxy)-4-methoxyphenethy)acetamide (4a).
A solution of 0.4 mL of acetyl chloride (5.6 mmol) in 5 mL anhydrous CH 2 Cl 2 was added dropwise at 0
• C to a solution of compound 3 (1.0 g, 3.88 mmol) and Et 3 N (1.7 mL, 12.26 mmol) in 20 mL anhydrous CH 2 Cl 2 , with stirring at 0
• C for 2 h. After the mixture was stirred, 2.5% aqueous HCl was added and the organic solution was washed with brine (2×10 mL) and H 2 O (2×10 mL), dried with anhydrous Na 2 SO 4 , evaporated to dryness, and pale-yellow solid was obtained. Crude product was crystallized with EtOAc to afford N- (3-benzyloxy-4- 
6-(benzyloxy)-7-methoxy-1-methyl-3,4-dihydroiso-quinoline (5a).
A solution of 0.9 mL of POCl 3 (9.8 mmol) in 6 mL anhydrous CH 2 Cl 2 was added dropwise at 40
• C to a solution of compound 4a (0.4 g, 1.06 mmol) in 10 mL anhydrous CH 2 Cl 2 , with stirring at 40
• C for 3 h, then was poured into ice-water mixture, 2.5% aqueous NaOH was added to make pH about 12, the aqueous solution was extracted with CH 2 Cl 2 (3 × 20 mL), and the organic solution was washed with brine (2×10 mL) and H 2 O (2×10 mL), dried with anhydrous Na 2 SO 4 , evaporated to dryness and solid was obtained. The crude product was purified with a silica gel column 
8-benzyloxy-9-methoxy-2-(2,4,5-trimethoxyphenyl)-5, 6-dihydropyrrolo[2,1-a]isoquinoline (I).
To a solution of 0.52 g compound 5a (1.85 mmol) in 15 mL anhydrous CH 3 CN was added 0.45 g 2-bromo-1-(2,4,5-trimethoxyphenyl)-ethanone (1.85 mmol). The reaction mixture was stirred at 85
• C for 10 h, then 0.38 g anhydrous K 2 CO 3 (2.75 mmol) was added and continued to stir for another 10 h. After that the mixture was poured into 15 mL brine and extracted with CH 2 Cl 2 (3 × 15 mL), the combined organic layers were dried with anhydrous Na 2 SO 4 , evaporated to dry, and brown oil was obtained. The crude product was purified with a silicagelcolumn (Petroleum : EtOAc(v/v) = 2 : 1, 200∼300 H) to afford 8-benzyl-9-methoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydropyrrolo [ 
N-(3,4-dimethoxyphenethyl)acetamide (4b).
A solution of 7.6 mL of acetyl chloride (0.11 mol) in 10 mL anhydrous CH 2 Cl 2 was added dropwise at 0
• C to a solution of compound 3b (10 mL, 0.059 mol) and Et 3 N (32.8 mL, 0.23 mol) in 25 mL anhydrous CH 2 Cl 2 , with stirring at 0
• C for 2 h. After the mixture was stirred, 2.5% aqueous HCl was added and the organic solution was washed with brine (2 × 30 mL) and H 2 O (2× 20 mL), dried with anhydrous Na 2 SO 4 , evaporated to dryness, and yellow solid was obtained. Crude product was crystallized with EtOAc to afford N-(3,4-dimethoxyphenethyl) acetamide (4b) ( 
6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline (5b).
A solution of 9.8 mL of POCl 3 (0.1 mol) in 40 mL anhydrous CH 2 Cl 2 was added dropwise at 40
• C to a solution of compound 4b (3.0 g, 13.4 mmol) in 30 mL anhydrous CH 2 Cl 2 , with stirring at 40
• C for 3 h, then was poured into ice-water mixture; 2.5% aqueous NaOH was added to make pH about 12, the aqueous solution was extracted with CH 2 Cl 2 (3 × 60 mL), and the organic solution was washed with brine (2 × 50 mL) and H 2 O (2 × 50 mL), dried with anhydrous Na 2 SO 4 , evaporated to dryness, and solid was obtained. The crude product was purified with a silica gel column (Petroleum : EtOAc(v/v) = 1 : 1, 200∼300 H) to afford 6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline (5b) (2.3 g, 83.6%) as brick red crystals. m.p. 98∼99
• C (lit. 17 m.p. 85∼96
• C) 1 
8,9-dimethoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydro [2,1-a]isoquinoline (II).
To a solution of 1.5 g compound 5b (7.32 mmol) in 20 mL anhydrous CH 3 CN was added 1.78 g 2-bromo-1-(2,4,5-trimethoxy-phenyl )-ethanone (7.34 mmol). The reaction mixture was stirred at 85
• C for 10 h, then 1.52 g anhydrous K 2 CO 3 (11.0 mmol) was added and continued to stir for another 10 h. After that the mixture was poured into 30 mL brine and extracted with CH 2 Cl 2 (3 × 30 mL), the combined organic layers were dried with anhydrous Na 2 SO 4 , evaporated to dryness, and brown oil was obtained. The crude product was purified with a silica gel column (Petroleum : EtOAc(v/v) = 2 : 1, 200∼300 H) to afford 8,9-dimethoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydro [ 
Results
The target compounds I and II had been synthesized by our route and their structures were determined by interpretation of spectral data. The 1 H NMR and 13 C NMR spectra of them were assigned as indicated in Figures 1, 2 5 , resulted from HR-MS data of I. The 13 C NMR spectrum of I displayed twenty-seven signals, which represented all twenty-nine C-atoms, eighteen of which were assignable to three aromatic-C moieties and accounted for sixteen spectral signals. Of the remaining eleven signals, four were from OMe (56.96, 56.97, 57.14, 57.43 ppm), and seven were from isoquinoline and pyrrole ring C-atoms.
NMR data of II (see Figures 3 and 4) indicated a C 23 H 25 framework, which HR-MS analysis expanded to a molecular formula of C 23 H 25 NO 5 . The simplest assumed relationship between the two isoquinoline, I as an BnOsubstituted II, was reinforced by characterization of the NMR data, which exhibited many similar signals. Specifically, too many shifts of H and C resonances are very similar to each other which proved the basic framework between I and II. The NMR signals which distinguished I from II were those of three aromatic protons appropriate for Ar-H (7.29-7.46 ppm, m, 5H) and -CH 2 -in the Ar-CH 2 O. The remaining distinguishing feature was the number of -OMesignal in 13 C NMR at 56-57 ppm.
Discussions
I and II from 1-methyl-3,4-dihydroisoquinoline and 2,4,5-trimethoxy-α-halogen-acetophenone were obtained with high yields under mild conditions for the first time. This novel method, as the key reaction step, provides a general and highly efficient method for the preparation of 5,6-dihydropyrrolo[2,1-a]isoquinolines. We envisaged that the 5,6-dihydropyrrolo[2,1-a]isoquinolines could be constructed by the formation of quaternary ammonium salt, and subsequent lactonization in the presence of anhydrous K 2 CO 3 . The negative carbon ion of 1-methyl-3,4-dihydroisoquinoline is also active in the Knorr reaction. Both 2,4,5-trimethoxy-α-bromoacetophenone and 2,4,5-trimethoxy-α-chloracetophenone were employed. We found that the yield of the former is about 5% higher than the later. Therefore, 2,4,5-trimethoxy-α-bromoacetophenone is used in the synthesis of I and II.
Conclusion
Based on the facile synthetic route depicted in Scheme 1, two novel scaffolds for synthesis of lamellarin analogues 8-benzyloxy-9-methoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydropyrrolo[2,1-a] isoquinoline (I) and 8,9-dimethoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydro[2,1-a]isoquinoline (II) were obtained under mild condition. These two compounds are characterized by 1 H NMR, 13 C NMR, IR spectrum, and melting points. The products are stable and may be expected to exhibit biological activities to some extend.
